研究报告 |
|
|
|
|
vMIP-II-TfN融合蛋白在毕赤酵母中的表达和纯化 |
王峰, 孙晗笑, 李秀英, 张光, 莫雪梅 |
暨南大学药学院基因组药物研究所 广州 510632 |
|
Expression and Purification of vMIP-II-TfN in Pichia pastoris |
WANG Feng, SUN Han-xiao, LI Xiu-ying, ZHANG Guang, MO Xue-mei |
Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou 510632, China |
引用本文:
王峰, 孙晗笑, 李秀英, 张光, 莫雪梅. vMIP-II-TfN融合蛋白在毕赤酵母中的表达和纯化[J]. 中国生物工程杂志, 2011, 31(10): 23-28.
WANG Feng, SUN Han-xiao, LI Xiu-ying, ZHANG Guang, MO Xue-mei. Expression and Purification of vMIP-II-TfN in Pichia pastoris. China Biotechnology, 2011, 31(10): 23-28.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I10/23
|
[1] Shao W, Fernandez E, Sachpatzidis A, et al. CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure. Eur J Biochem, 2001, 268(10):2948-2959.
[2] Kledal T N, Rosenkilde M M, Coulin F, et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science, 1997, 277:1656-1659.
[3] Holst P J, Luttichau H R, Schwartz T W, et al. Virally encoded chemokines and chemokine receptors in the role of viral infections. Contrib Microbiol, 2003, 10:232-252.
[4] Morris K V, Higgins J, Shen X, et al. The effects of HHV-8 vMIP-II on SIVmac251 infection and replication competent and incompetent SIVmac239Delta3 vectors. Virus Research, 2003, 94:103-112.
[5] 莫雪梅, 叶石敦, 张光, 等. 广谱趋化因子受体结合物-vMIP-II的体内抗SIV功能研究. 中国病毒学, 2005, 20:459-463. Mo X M, Ye S D, Zhang G, et al. Virologica Sinica, 2005, 20:459-463.
[6] Widera A, Norouziyan F, Shen W C. Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery. Adv Drug Deliv Rev, 2003, 55(11):1439-1466.
[7] Bai Y, Ann D K, Shen W C. Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci USA, 2005, 102(20):7292-7296.
[8] Sallach R E, Conticello V P, Chaikof E L. Expression of a recombinant elastin-like protein in Pichia pastoris. Biotechnol Prog, 2009, 25(6):1810-1818.
[9] Cregg J M, Vedvick T S, Raschke W C. Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology, 1993, 11(8):905-910.
[10] Daly R, Hearn M T. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit, 2005, 18(2):119-138.
[11] Pack P, Pluckthun A. Mini-antibodies: use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli. Biochemistry, 1992, 31(6):1579-1584.
[12] Lambert L A, Perri H, Meehan T J. Evolution of duplications in the transferrin family of proteins. Comp Biochem Physiol B Biochem Mol Biol, 2005, 140(1):11-25.
[13] Steinlein L M, Graf T N, Ikeda R A. Production and purification of N-terminal half-transferrin in Pichia pastoris. Protein Expr Purif, 1995, 6(5):619-624.
[14] Xia C Q, Wang J, Shen W C. Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther, 2000, 295(2):594-600.
[15] 李晓静, 张豪, 薛冲, 等. 干扰素与转铁蛋白融合蛋白在毕赤酵母中的表达及鉴定. 生物化学与生物物理进展, 2005, 32(7):625-629. Li X J, Zhang H, Xue C, et al. Progress in Biochemistry and Biophysics, 2005, 32(7):625-629.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|